https://www.selleckchem.com/pr....oducts/n-ethylmaleim
No significant change was noted in the CRBSI rates following this switch (0.27/1000 catheter days receiving customized HPN vs 0.21/1000 catheter days on MCBs; incidence rate ratio, 1.31; 95% CI, 0.12-14.3). The use of MCBs for HPN patients is not associated with an increased risk of CRBSI. This study will inform international guidelines and provide reassurance for the continued, safe use of MCB HPN. The use of MCBs for HPN patients is not associated with an increased risk of CRBSI. This study will inform international guide
Like
Comment
Share
